These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1840681)

  • 1. Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model.
    Corominas M; Leon J; Kamino H; Cruz-Alvarez M; Novick SC; Pellicer A
    Oncogene; 1991 Apr; 6(4):645-51. PubMed ID: 1840681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
    Kumar R; Medina D; Sukumar S
    Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.
    Jhappan C; Takayama H; Dickson RB; Merlino G
    Cell Growth Differ; 1994 Apr; 5(4):385-94. PubMed ID: 8043512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of the H-ras mutated and normal alleles in rabbit DMBA-induced keratoacanthomas.
    Matesanz F; Oliva MR; Villamarin A; Kamino H; Pellicer A
    Int J Cancer; 1995 May; 61(5):679-82. PubMed ID: 7539411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
    Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
    Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ras activation in human tumors and in animal model systems.
    Corominas M; Sloan SR; Leon J; Kamino H; Newcomb EW; Pellicer A
    Environ Health Perspect; 1991 Jun; 93():19-25. PubMed ID: 1773791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.
    Manam S; Storer RD; Prahalada S; Leander KR; Kraynak AR; Ledwith BJ; van Zwieten MJ; Bradley MO; Nichols WW
    Cancer Res; 1992 Jun; 52(12):3347-52. PubMed ID: 1596892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-ras mutation in ultraviolet radiation-induced murine skin cancers.
    Pierceall WE; Kripke ML; Ananthaswamy HN
    Cancer Res; 1992 Jul; 52(14):3946-51. PubMed ID: 1617670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-ras activation in benign and self-regressing skin tumors (keratoacanthomas) in both humans and an animal model system.
    Leon J; Kamino H; Steinberg JJ; Pellicer A
    Mol Cell Biol; 1988 Feb; 8(2):786-93. PubMed ID: 3127691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras.
    Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J
    Cancer Res; 2000 Oct; 60(20):5688-95. PubMed ID: 11059761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-type-specific ras mutations but no microsatellite instability in chemically induced mouse skin tumors and transformed 3T3 cells.
    Sasaki K; Bertrand O; Nakazawa H; Fitzgerald DJ; Mironov N; Yamasaki H
    Cancer Res; 1995 Aug; 55(16):3513-6. PubMed ID: 7627957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 x C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens.
    Fox TR; Schumann AM; Watanabe PG; Yano BL; Maher VM; McCormick JJ
    Cancer Res; 1990 Jul; 50(13):4014-9. PubMed ID: 2191770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ras gene activation in rat tumors induced by benzidine congeners and derived dyes.
    Reynolds SH; Patterson RM; Mennear JH; Maronpot RR; Anderson MW
    Cancer Res; 1990 Jan; 50(2):266-72. PubMed ID: 2403837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure.
    Yuan B; Heniford BW; Ackermann DM; Hawkins BL; Hendler FJ
    Cancer Res; 1994 Oct; 54(20):5310-7. PubMed ID: 7923158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
    Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H
    Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.